MP
MapLight Therapeutics, Inc.
MPLT · NASDAQ
$10.92 -2.59% (-$0.29)
1M -3.87%
Market Cap $463.4M
P/E Ratio -
Div. Yield -
ROE 63.84%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 1.33x
EV/EBITDA N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 180.05%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 63.84%
ROA 62.39%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 16.52x
Debt/Equity 0.01x
Net debt/EBITDA N/A
Stability
30 /100
Unstable EPS volatility 30.04%
Profitable years 0
Beta 2.57x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na MPLT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher A. Kroeger
Employees
133
Headquarters
Redwood City
Nadcházející události
03 PRO
Earnings
Upcoming earnings report